TMDX - TransMedics draws bullish view at Piper Sandler on valuation
2024-03-28 12:32:02 ET
More on TransMedics Group
- TransMedics: Strong Business, Fully Valued Stock
- TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
- TransMedics Group: Huge Opportunity In Organ Transplants
- TransMedics Group GAAP EPS of $0.12 beats by $0.16, revenue of $81.2M beats by $12.7M
- TransMedics Group Q4 2023 Earnings Preview